Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplasms 5Glioblastoma 4Lung Neoplasms 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Glioma 2Colorectal Neoplasms 2Breast Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Thyroid Nodule 1Stomach Neoplasms 1Prostatic Neoplasms 1Pleural Neoplasms 1Pancreatic Cyst 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Mesothelioma 1Medication Adherence 1Margins of Excision 1Lymphedema 1Lung Diseases 1Liver Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Early-stage Peripheral Non-small Cell Lung Cancer 1

Interventions

Sorafenib 202lenvatinib 129Bevacizumab 124Nivolumab 85pembrolizumab 72atezolizumab 72Radiosurgery 71durvalumab 63Oxaliplatin 59sintilimab 57Fluorouracil 54Doxorubicin 44tislelizumab 43apatinib 43Leucovorin 40tremelimumab 37camrelizumab 37Radiofrequency Ablation 37Radiotherapy 36Magnetic Resonance Spectroscopy 32Capecitabine 30regorafenib 29Folfox protocol 29Cisplatin 28cabozantinib 26Hepatectomy 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25toripalimab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Hepatocellular × Drug Delivery Systems × Clear all
NCT05903456 2023-06-15

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Zhejiang Cancer Hospital

Phase 2 Unknown
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02828865 2020-07-07

A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers

National Taiwan University Hospital

Phase NA Completed
18 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01078415 2016-11-08

Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)

Angiodynamics, Inc.

Phase NA Completed
26 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡